We congratulate Yohei Doi, MD, PhD, on his promotion to Professor of Medicine at the University of Pittsburgh! Dr. Doi is the chair for ARLG’s Gram-Negative Committee which advances research and improves patient outcomes by designing clinical trials for gram-negative infections and mentoring ARLG junior investigators.

Dr. Doi also serves as the Director of the Center for Innovative Antimicrobial Therapy (CIAT) at the University of Pittsburgh as well as the Professor and Chair of Microbiology at Fujita Health University in Aichi, Japan. His primary topics of research include the genetic and molecular basis of emerging antimicrobial resistance mechanisms, inhibitor-based drug discovery, colistin resistance in Acinetobacter baumannii, and the rapid diagnosis of resistance using phenotypic, genetic, and lipidomic approaches.